China’s Efforts To Develop Anti-Ebola Drugs Illustrate Opportunities, Challenges In R&D, Ensuring Global Health Security

Council on Foreign Relations’ “Asia Unbound”: A Tale of Two Anti-Ebola Drugs
Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations, discusses China’s experience developing experimental anti-Ebola drugs, writing, “[T]he story of China’s efforts to develop anti-Ebola drugs is illustrative of the opportunities and challenges we face in ensuring global health security. … Unfortunately, intellectual property issues remain an insurmountable hurdle for China to … serve as a real leader in [global health security]. New norms and rules will be needed to balance public health and intellectual property considerations in pursuing and promoting global health security” (6/16).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.